Artificial 5'UTR ribonucleotide sequence, artificial 5'UTR-encoding deoxyribonucleotide sequence, uses of the artificial 5'UTR ribonucleotide sequence, artificial ribonucleic acid molecule and its use, and artificial ribonucleic acid molecule for use as a vaccine

PL451953A1Pending Publication Date: 2026-11-09GOSUDARSTVENNOE NAUCHNOE UCHREZHDENIE INST BIOORGANICHESKOY KHIMII NATSIONALNOY AKADI NAUK BELARUSI
0 Cites 0 Cited by

Patent Information

Application Number
PL2025451953
Authority / Receiving Office
PL · PL
Patent Type
Applications
Current Assignee / Owner
Filing Date
2025-05-05
Publication Date
2026-11-09
Patent Text Reader

Abstract

The subject of the application is an artificial 5' untranslated region (5' UTR) ribonucleotide sequence and an artificial 5'UTR deoxyribonucleotide sequence encoding it, derived from the 5'UTR of the genes of the α2 subunit of human laminin or the α1 subunit of human laminin or from a mutated 5'UTR sequence of the Encephalomyocarditis virus (EMCV), and the use of the artificial 5'UTR ribonucleotide sequence in the in vitro production of an artificial ribonucleic acid (RNA) molecule by transcription.The subject of the application is also an artificial RNA molecule characterized in that it contains in its 5'UTR the artificial 5'UTR ribonucleotide sequence mentioned above, encoded by the artificial 5'UTR deoxyribonucleotide sequence mentioned above, as well as the use of the artificial 5'UTR ribonucleotide sequence and the artificial RNA molecule in the in vitro production of a heterologous protein in mammalian cells cultured in vitro and / or in translation systems based on mammalian cells, preferably in mammalian cells that are human cells. The subject of the application is also an artificial RNA molecule for use as a vaccine.
Need to check novelty before this filing date? Find Prior Art